Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Feb 2;99(2):293–307. doi: 10.1093/biolre/ioy030

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018. Published by Oxford University Press on behalf of Society for the Study of Reproduction.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

Figure 1. — Immunostaining intensity for EZH2α in endometriotic lesions and endometrium from patients and controls. Immunostaining of EZH2α in glands and stroma was analyzed by three independent scorers using an intensity scale (2 = strong, 1 = weak, and 0 = no staining). Immunostaining was reported as mean intensity ± SEM. No significant differences based on the immunostaining intensity for EZH2α was observed among the different lesions type neither in glands nor stroma. Significant higher intensity of EZH2α was observed in the glands of the secretory endometrium from patients compared to proliferative endometrium from patients (SE patients vs. PE patients P = 0.0254).